Creative BioMart, a leading provider of recombinant proteins, today announced that it has expanded its offerings of proteins related to the Monkeypox virus. These proteins, which are available to researchers, have the potential to aid in the development of vaccines, antiviral drugs, diagnostic tools, and a deeper understanding of the virus’s pathology.
The outbreak of Monkeypox in non-endemic areas has highlighted the need for further research into this disease. While smallpox vaccines have shown to be approximately 85% effective against Monkeypox, there is currently no dedicated vaccine available. Additionally, treatment options are limited, with Tecovirimat, a drug that targets the orthopoxvirus VP37 protein, being one of the few approved treatments.
“Creative BioMart is committed to supporting the scientific community in their efforts to combat emerging infectious diseases,” said Linna, the chief marketing staff at Creative BioMart. “By providing researchers with access to Monkeypox-related proteins, we hope to accelerate the development of much-needed countermeasures against this virus.”
The proteins offered by Creative BioMart are designed based on the gene sequence of the Monkeypox virus and have the potential to be used in a variety of applications. For example, they could be used to study the structure and function of key viral proteins, which could inform the development of antiviral drugs. They could also be used to develop improved diagnostic tests, which are critical for tracking and controlling outbreaks.
Some of the Monkeypox Virus-related Proteins products at Creative BioMart include:
Recombinant Monkeypox A5L and A11L Fusion Antigen
Recombinant Monkeypox virus (strain Zaire-96-I-16) E8L protein, His-Avi-tagged, Biotinylated
Recombinant Monkeypox virus (strain Zaire-96-I-16) E8L protein, His-tagged
Recombinant Monkeypox Virus 13 Protein, IL-18 binding Protein (Interleukin-18-binding Protein)
Recombinant Monkeypox Virus 147 Protein, Cowpox A-type inclusion Protein
…
Creative BioMart’s Monkeypox virus proteins are meticulously purified to ensure minimal contamination, providing researchers with reliable and reproducible results. Validated through rigorous testing, these proteins retain their functional and structural integrity, mirroring natural viral proteins. They are ideal for use in diagnostic assay development, vaccine research, antibody production, and antiviral drug discovery, and can be customized to meet specific research needs.
While the potential applications of these proteins are promising, the company notes that the successful development of vaccines, drugs, and diagnostics is a complex process that requires further research. However, by making these proteins available to researchers, Creative BioMart hopes to play a part in advancing the understanding of the Monkeypox virus and the development of effective countermeasures.
Researchers interested in learning more about Creative BioMart’s Monkeypox-related proteins can visit https://www.creativebiomart.net/product/monkeypox-virus-related-proteins_4114.htm.
About Creative BioMart
Creative BioMart is a leading provider of recombinant proteins, offering a wide range of proteins from various species and viruses. The company is committed to supporting the scientific community in their research efforts, particularly in the area of emerging infectious diseases.